Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Journal of Translational Medicine
|
January 18, 2024
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium
Sherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Life (Basel, Switzerland)
|
September 28, 2021
A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response
Tiziana Siciliano, Ingo H Simons, Alicia-Marie K Beier, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells
Ulrich Sommer, Tiziana Siciliano, Celina Ebersbach, et al.
Oncogenesis
|
May 30, 2017
The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling
G Nappo, F Handle, F R Santer, et al.
Plos One
|
August 14, 2020
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer
Holger H H Erb, Julia Bodenbender, Florian Handle, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism Manipulation
Pia V Hönscheid, Gustavo B Baretton, Martin Puhr, et al.
Endocrine-Related Cancer
|
August 6, 2013
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9
Holger H H Erb, Regina V Langlechner, Patrizia L Moser, et al.
Molecular Cancer Therapeutics
|
June 29, 2011
Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines
Frédéric R Santer, Philipp P S Höschele, Su Jung Oh, et al.
European Urology
|
June 20, 2018
Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures
Fabian Guggenberger, Harmen J G van de Werken, Holger H H Erb, et al.
Molecular Cancer Therapeutics
|
September 27, 2018
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
Florian Handle, Martin Puhr, Georg Schaefer, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Journal of Translational Medicine
|
January 18, 2024
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium
Sherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Life (Basel, Switzerland)
|
September 28, 2021
A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response
Tiziana Siciliano, Ingo H Simons, Alicia-Marie K Beier, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells
Ulrich Sommer, Tiziana Siciliano, Celina Ebersbach, et al.
Oncogenesis
|
May 30, 2017
The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling
G Nappo, F Handle, F R Santer, et al.
Plos One
|
August 14, 2020
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer
Holger H H Erb, Julia Bodenbender, Florian Handle, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism Manipulation
Pia V Hönscheid, Gustavo B Baretton, Martin Puhr, et al.
Endocrine-Related Cancer
|
August 6, 2013
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9
Holger H H Erb, Regina V Langlechner, Patrizia L Moser, et al.
Molecular Cancer Therapeutics
|
June 29, 2011
Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines
Frédéric R Santer, Philipp P S Höschele, Su Jung Oh, et al.
European Urology
|
June 20, 2018
Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures
Fabian Guggenberger, Harmen J G van de Werken, Holger H H Erb, et al.
Molecular Cancer Therapeutics
|
September 27, 2018
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
Florian Handle, Martin Puhr, Georg Schaefer, et al.
Page
of 11